Teva Defends Mifepristone Antitrust Case Against Corcept
Teva Pharmaceuticals has told a California federal court there is plenty of evidence for a jury to find that Corcept Therapeutics blocked generic competition for its cortisol disorder treatment Korlym by...To view the full article, register now.
Already a subscriber? Click here to view full article